High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag

High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag

Journal Title: 
Leukemia
Primary Author: 
Kohei Hosokawa
Author(s): 
Kohei Hosokawa, Hirohito Yamazaki, Mikoto Tanabe, Tatsuya Imi, Naomi Sugimori, Shinji Nakao
Original Publication Date: 
Friday, July 3, 2020
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/32616921/
Bone Marrow Disease(s): 
  • aplastic anemia
Share with addtoany.com.